Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Spreafico

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|May 25, 2013
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuriaAdriano Spreafico, Lia Millucci, Lorenzo Ghezzi, et al.
Biomacromolecules|December 13, 2006
Novel therapeutic agents for bone resorption. Part 1. Synthesis and protonation thermodynamics of poly(amido-amine)s containing bis-phosphonate residuesMario Casolaro, Ilaria Casolaro, Adriano Spreafico, et al.
Plos One|August 5, 2011
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failureLia Millucci, Eugenio Paccagnini, Lorenzo Ghezzi, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 2021
Screening of Organ-Specific Autoantibodies in a Large Cohort of Patients with Autoimmune Thyroid DiseasesTania Pilli, Gilda Dalmazio, Brunetta Porcelli, et al.
Journal of Cellular Physiology|July 22, 2010
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell modelLaura Tinti, Adriano Spreafico, Daniela Braconi, et al.
Calcified Tissue International|March 9, 2017
Histological and Ultrastructural Characterization of Alkaptonuric TissuesLia Millucci, Giulia Bernardini, Adriano Spreafico, et al.
Journal of Cellular Physiology|March 27, 2015
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma PatientsMarcella Laschi, Giulia Bernardini, Michela Geminiani, et al.
Molecular Biosystems|March 12, 2014
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcomaGiulia Bernardini, Marcella Laschi, Tommaso Serchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 4, 2008
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cellsAdriano Spreafico, Silvia Schenone, Tommaso Serchi, et al.
Mediators of Inflammation|May 31, 2014
Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patientLia Millucci, Lorenzo Ghezzi, Eugenio Paccagnini, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|May 25, 2013
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuriaAdriano Spreafico, Lia Millucci, Lorenzo Ghezzi, et al.
Biomacromolecules|December 13, 2006
Novel therapeutic agents for bone resorption. Part 1. Synthesis and protonation thermodynamics of poly(amido-amine)s containing bis-phosphonate residuesMario Casolaro, Ilaria Casolaro, Adriano Spreafico, et al.
Plos One|August 5, 2011
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failureLia Millucci, Eugenio Paccagnini, Lorenzo Ghezzi, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 2021
Screening of Organ-Specific Autoantibodies in a Large Cohort of Patients with Autoimmune Thyroid DiseasesTania Pilli, Gilda Dalmazio, Brunetta Porcelli, et al.
Journal of Cellular Physiology|July 22, 2010
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell modelLaura Tinti, Adriano Spreafico, Daniela Braconi, et al.
Calcified Tissue International|March 9, 2017
Histological and Ultrastructural Characterization of Alkaptonuric TissuesLia Millucci, Giulia Bernardini, Adriano Spreafico, et al.
Journal of Cellular Physiology|March 27, 2015
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma PatientsMarcella Laschi, Giulia Bernardini, Michela Geminiani, et al.
Molecular Biosystems|March 12, 2014
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcomaGiulia Bernardini, Marcella Laschi, Tommaso Serchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 4, 2008
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cellsAdriano Spreafico, Silvia Schenone, Tommaso Serchi, et al.
Mediators of Inflammation|May 31, 2014
Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patientLia Millucci, Lorenzo Ghezzi, Eugenio Paccagnini, et al.
Pageof 4